|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01513 LIVZON PHARMA
Nominal 
26.250 +0.150 (+0.575%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 3,248,934 | 2,772,671 | 1,902,328 | 2,160,761 |
| Net Cash from / (used in) Investing Activities | -- | (708,374) | (1,229,870) | (1,876,900) | (467,844) |
| Net Cash from / (used in) Financing Activities | -- | (1,656,881) | (720,356) | (815,018) | (518,042) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 883,680 | 822,446 | (789,590) | 1,174,874 |
| Cash & Cash Equivalents at beginning of period | -- | 10,072,643 | 9,125,310 | 9,952,050 | 8,854,186 |
| Effect of Foreign Exchange Rate Changes | -- | 20,044 | 124,887 | (37,150) | (77,010) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 10,976,366 | 10,072,643 | 9,125,310 | 9,952,050 |
| Remarks: | Real time quote last updated: 18/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,170,971 |
| %Change | 3.208% |
| EPS / (LPS) | RMB 1.270 |
| NBV Per Share (¥) | RMB 15.027 |